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Iron deficiency is one of the most common nutritional 
problems in the world and the leading cause of 
anaemia in children and pregnant women.[1] In South 
Africa (SA), iron deficiency and anaemia constitute a 
significant disease burden owing to chronic helminth 
infections and a predominantly cereal-based diet.[2]
Iron deficiency is treatable. Successful management of iron 
deficiency anaemia (IDA) requires accurate diagnosis followed by 
investigation of the underlying cause of iron loss and treatment with 
iron supplements. Accurate diagnosis demands differentiation of 
IDA from the anaemia of chronic disease (ACD), also referred to as 
anaemia of inflammation. In hospital patients, chronic infection(s) 
and inflammation often coexist with iron deficiency. In SA there is 
a high burden of chronic infections such as tuberculosis and HIV.[3] 
Anaemia has been reported in up to 95% of HIV patients, reflecting 
cytokine dysregulation, drug therapy, presence of infection, presence 
of malignancy and/or nutritional deficiencies.[4]
The distinction between concomitant iron deficiency and ACD is 
often difficult. Characteristically ACD is a mild to moderate anaemia 
(haemoglobin concentration 8.0 - 9.5 g/dL), which is normocytic 
and normochromic. However, ACD may also be microcytic and/or 
hypochromic. It is then important to distinguish it from true IDA, so 
that appropriate supplementaion can be administered.
Laboratory investigations
Bone marrow (BM) biopsy and iron staining is considered the 
gold standard test for the diagnosis of iron deficiency. However, 
BM biopsy is an invasive procedure and is no longer considered 
the standard of care for assessment of iron stores.[5] In everyday 
clinical practice, IDA and ACD are traditionally differentiated by 
assessment of iron studies, which include serum iron, transferrin, 
transferrin saturation and ferritin (Table 1).[6] A low ferritin level is 
highly sensitive for the diagnosis of IDA, but ferritin is also an acute-
phase reactant showing an increase in the presence of infection or 
inflammation when iron is sequestered in reticuloendothelial 
system macrophages. A normal ferritin level therefore does not 
exclude accompanying IDA.[7] This is evident by the reduced ferritin 
sensitivity of 46.4% at the clinically recommended cut-off of 30 
µg/L in hospital patients.[3]
More recently, automated analysers can perform tests that are 
reported to be independent of infection and inflammation. These 
include biochemical parameters, namely zinc protoporphyrin and 
soluble transferrin receptor, as well as haematological parameters, 
namely the percentage of hypochromic red blood cells, and 
reticulocyte parameters such as the reticulocyte haemoglobin 
content (CHr). The advantage of measuring the haemoglobin of the 
reticulocyte is that the reticulocyte has a shorter lifespan (1 - 2 days) 
than the red cell. CHr therefore provides an early indicator of iron 
deficiency.[8]
The reticulocyte haemoglobin content
The CHr is a measure of the product of the reticulocyte haemoglobin 
concentration and the mean cell volume. Several recent studies[8-11] 
have confirmed the diagnostic performance of the CHr, which is 
routinely available.
At the National Health Laboratory Service Haematology Lab-
oratory at Charlotte Maxeke Johannesburg Academic Hospital, 
SA, we performed a prospective study in 74 hospital patients in 
order to compare the accuracy of the CHr with that of standard 
haematological and biochemical tests for the diagnosis of IDA using 
the BM iron stain as the reference.[3] In this study, a CHr of >28 pg 
reliably distinguished IDA from ACD with a sensitivity of 75.86% 
and a specificity of 84.10%. CHr is therefore a good discriminator 
of IDA.
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The diagnosis of iron deficiency anaemia in hospital patients with chronic infections and inflammation presents a challenge. Recently 
laboratory tests such as the reticulocyte haemoglobin content, which are independent of infection and inflammation, have become available 
for routine diagnostic use.
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However, the diagnostic CHr cut-off values 
vary according to the study population and 
diagnostic inclusion criteria, emphasising the 
importance of determining the CHr cut-off 
for each specific patient population.
In a study by Karlsson,[10] a higher CHr 
cut-off of 30.5 pg, corresponding to a 
sensitivity of 93% and a specificity of 69%, 
was shown to be indicative of IDA in 54 
elderly patients. Studies performed in elderly 
patients have reported a higher mean cell 
volume (MCV) and mean cell haemoglobin 
(MCH) in the IDA and ACD groups.[10,12]
A study performed at Pelonomi Regional 
Hospital, SA, in 100 infants and children 
aged 6 months - 6 years showed that the 
optimal CHr cut-off for the diagnosis of iron 
deficiency was 29 pg. This corresponded to 
a sensitivity of 86% and a specificity of 50%, 
using a transferrin saturation of <25% as the 
diagnostic criterion for iron deficiency.[13]
The CHr has been compared with stan dard 
haematological and biochemical tests for the 
diagnosis of IDA. We found that the sensi-
tivity of the CHr was not superior to the MCH 
parameter or the transferrin saturation, which 
is similar to the results of two other studies 
performed in hospital patients in which the 
authors also concluded that the CHr does not 
perform better than standard tests for IDA. [10,12] 
Further studies are required in order to identify 
an improved marker of iron deficiency in 
hospital patients compared with standard 
biochemical and haematological tests.
The CHr test has several advantages. It is a 
simple and cost-effective test. The current 
diagnostic panel for IDA, which includes a 
full blood count (FBC), peripheral smear 
review and iron studies, costs approximately 
ZAR610.00. A test panel based on the 
haematological parameters of FBC and CHr 
(as part of the reticulocyte count) costs 
approximately ZAR220.00. The CHr can 
be performed on 1 - 1.5 mL of blood in a 
single EDTA tube and in children a finger 
prick would produce an adequate sample, 
eliminating the need for additional tubes for 
the biochemical parameters.
The CHr test does have some obvious 
current limitations for routine use in 
that it can only be measured by ADVIA 
haematology analysers (Siemens Diagnostics, 
USA), the availability of which is laboratory 
specific. However, more recently reticulocyte 
parameters (Ret-He and Ret-Y) on the 
Sysmex haematology analyser (Sysmex 
Corporation, Japan) have shown good 
agreement with the CHr.[12,14] Also, since the 
CHr is calculated from the reticulocyte MCV, 
patients with haemoglobinopathy associated 
with microcytosis will have a falsely low CHr, 
while patients with megaloblastic anaemia or 
macrocytic indices (MCV >100 fl), including 
some patients on antiretroviral therapy, 
will have a falsely elevated CHr.[15] For the 
clinician, it is important to interpret the CHr 
in the context of the patient’s other clinical 
and laboratory investigations including red 
cell indices, vitamin B12, folate levels and 
findings on haemoglobin electrophoresis.
Conclusion
The diagnostic distinction between IDA, 
ACD and the combined state of IDA and 
ACD in hospital patients with chronic 
infections and inflammation can be diffi cult 
with standard biochemical and haemato-
logical tests. Although the CHr test is not 
superior to standard tests for IDA, it is 
a simple and cost-effective alternative to 
biochemical and haematological parameters 
for the diagnosis of IDA in hospital patients. 
It is recommended that in hospital patients 
with anaemia a C-reative protein (CRP), or 
other biochemical markers of inflammation, 
and a CHr be added to the initial FBC 
assessment. If the CRP is elevated, IDA can 
be diagnosed in patients with coexistent 
ACD in the presence of a CHr  <28  pg and 
hypochromic red cell indices.
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Table 1. Laboratory findings in, ACD and combined iron deficiency anaemia and 
anaemia of chronic disease (IDA and ACD)[3] 
Laboratory test IDA ACD IDA and ACD
Haematology
MCV ↓ ↓ or normal ↓ or normal
MCH ↓ ↓ or normal ↓ or normal
Bone marrow iron stores ↓ ↑ ↓ or normal
CHr (pg) <28 ≥28 <28
Hypochromic red blood cells (%) >5 <5 >5
Biochemistry
Iron ↓ ↓ ↓
Transferrin ↑ ↓ or normal ↓
Transferrin saturation ↓ ↓ ↓
Ferritin ↓ ↑ ↓ or normal
sTfR ↑ Normal Normal or ↑
sTfR-ferritin index High (>2) ↓ High (>2)
Zinc proptoporphyrin ↑ Normal Normal or ↑
CRP Normal ↑ ↑
Hepcidin ↓ ↑ ↑
MCV = mean cell volume; MCH = mean cell haemoglobin; sTfR = soluble transferrin receptor; CRP = C-reactive protein.
